Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,250 | 33,117 | 101,856 | 127,011 | 39,615 |
| Marketable Securities | 76,633 | 182,387 | 187,497 | 185,007 | 87,647 |
| Receivables | 10,048 | 2,657 | 14,906 | 10,360 | 3,346 |
| Inventories | 2,722 | 13,995 | 11,090 | N/A | N/A |
| Other current assets | 8,956 | 7,405 | 4,831 | 6,438 | 2,596 |
| TOTAL | $125,609 | $239,561 | $320,180 | $328,816 | $133,204 |
| Non-Current Assets | |||||
| PPE Net | 28,454 | 34,790 | 59,094 | 28,245 | 22,625 |
| Investments And Advances | 5,307 | 1,375 | 570 | 5,606 | 12,491 |
| Intangibles | 45,201 | 50,737 | 49,653 | 49,096 | 14,315 |
| Other Non-Current Assets | 3,854 | 8,479 | 9,186 | 5,298 | 621 |
| TOTAL | $82,816 | $95,381 | $118,503 | $88,245 | $50,052 |
| Total Assets | $208,425 | $334,942 | $438,683 | $417,061 | $183,256 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,546 | 16,477 | 21,435 | 9,837 | 4,607 |
| Accounts payable and accrued liabilities | 6,967 | 3,720 | 5,524 | 6,126 | 2,231 |
| Accrued Expenses | 11,713 | 10,676 | 10,124 | 9,588 | 5,027 |
| Other current liabilities | N/A | N/A | 5,193 | N/A | N/A |
| TOTAL | $43,416 | $45,557 | $75,950 | $48,247 | $14,636 |
| Non-Current Liabilities | |||||
| Long Term Debt | 111,611 | 88,397 | 67,893 | 125,710 | 102,254 |
| Deferred Revenues | 14,190 | 14,684 | 33,674 | 22,696 | 2,771 |
| Other Non-Current Liabilities | 125,000 | 125,000 | 125,000 | 0 | 0 |
| TOTAL | $237,142 | $222,207 | $207,256 | $145,715 | $102,254 |
| Total Liabilities | $280,558 | $267,764 | $283,206 | $193,962 | $116,890 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,528 | 55,884 | 55,381 | 53,958 | N/A |
| Common Shares | 57 | 56 | 55 | 54 | 40 |
| Retained earnings | -698,447 | -555,583 | -459,893 | -386,591 | -311,460 |
| Other shareholders' equity | 2,551 | 15,197 | 11,348 | 24,445 | 23,298 |
| TOTAL | $-72,133 | $67,178 | $155,477 | $223,099 | $66,366 |
| Total Liabilities And Equity | $208,425 | $334,942 | $438,683 | $417,061 | $183,256 |